Cargando…

Perilesional Targeted Biopsy Combined with MRI-TRUS Image Fusion-Guided Targeted Prostate Biopsy: An Analysis According to PI-RADS Scores

A prostate-targeted biopsy (TB) core is usually collected from a site where magnetic resonance imaging (MRI) indicates possible cancer. However, the extent of the lesion is difficult to accurately predict using MRI or TB alone. Therefore, we performed several biopsies around the TB site (perilesiona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomioka, Masayuki, Seike, Kensaku, Uno, Hiromi, Asano, Nami, Watanabe, Haruo, Tomioka-Inagawa, Risa, Kawase, Makoto, Kato, Daiki, Takai, Manabu, Iinuma, Koji, Tobisawa, Yuki, Nakane, Keita, Tsuchiya, Kunihiro, Ito, Takayasu, Koie, Takuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417101/ https://www.ncbi.nlm.nih.gov/pubmed/37568971 http://dx.doi.org/10.3390/diagnostics13152608

Ejemplares similares

The accuracy of prostate cancer diagnosis in biopsy-naive patients using combined magnetic resonance imaging and transrectal ultrasound fusion-targeted prostate biopsy
por: Uno, Hiromi, et al.
Publicado: (2021)

Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer
por: Sugino, Fumiya, et al.
Publicado: (2023)

Efficacy and Safety of the “Trisection Method” Training System for Robot-Assisted Radical Cystectomy at a Single Institution in Japan
por: Nakane, Keita, et al.
Publicado: (2022)

Clinical Predictors of Grade Group Upgrading for Radical Prostatectomy Specimens Compared to Those of Preoperative Needle Biopsy Specimens
por: Tomioka, Masayuki, et al.
Publicado: (2022)

Perilesional sampling: the new standard for imaging-targeted prostate biopsies?
por: Thomas, Christian
Publicado: (2023)

A Case Report of Syphilis That Was Difficult to Distinguish From Penile Carcinoma
por: Tomioka, Masayuki, et al.
Publicado: (2023)

Ghrelin after chemotherapy as a prognostic predictor of progression-free survival in patients with muscle-invasive bladder cancer
por: Tomioka, Masayuki, et al.
Publicado: (2021)

The Impact of Neutrophil-to-Lymphocyte Ratio after Two Courses of Pembrolizumab for Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma
por: Tomioka-Inagawa, Risa, et al.
Publicado: (2022)

Multiparametric MRI-Targeted TRUS Prostate Biopsies Using Visual Registration
por: Puech, Philippe, et al.
Publicado: (2014)

How to Improve TRUS-Guided Target Biopsy following Prostate MRI
por: Park, Byung Kwan
Publicado: (2021)

Efficacy and Safety of Cabozantinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study
por: Iinuma, Koji, et al.
Publicado: (2022)

MRI-TRUS fusion targeted biopsy is highligheted in International Brazilian Journal of Urology
por: Favorito, Luciano A.
Publicado: (2023)

Is it necessary for all patients with suspicious lesions undergo systematic biopsy in the era of MRI-TRUS fusion targeted biopsy?
por: Lv, Zhengtong, et al.
Publicado: (2023)

Robot-Assisted Radical Prostatectomy for Potential Cancer Control in Patients with Metastatic Prostate Cancer
por: Takagi, Kimiaki, et al.
Publicado: (2022)

Comparison of pain levels in fusion prostate biopsy and standard TRUS-Guided biopsy
por: Demirtaş, Abdullah, et al.
Publicado: (2020)

MR-targeted TRUS prostate biopsy using local reference augmentation: initial experience
por: van de Ven, Wendy J. M., et al.
Publicado: (2016)

Leptomeningeal Carcinomatosis in Urothelial Carcinoma of the Urinary Bladder: A Report of a Patient with a Fulminant Course Who Died of Cancer after Definitive Therapies
por: Tomioka, Masayuki, et al.
Publicado: (2021)

The Utility of Combined Target and Systematic Prostate Biopsies in the Diagnosis of Clinically Significant Prostate Cancer Using Prostate Imaging Reporting and Data System Version 2 Based on Biparametric Magnetic Resonance Imaging
por: Kato, Daiki, et al.
Publicado: (2021)

Analysis of the cause of missed diagnosis in mpMRI/TRUS fusion-guided targeted prostate biopsy
por: Zhang, Fan, et al.
Publicado: (2022)

Bi-parametric MRI/TRUS fusion targeted repeat biopsy after systematic 10-12 core TRUS-guided biopsy reveals more significant prostate cancer especially in anteriorly located tumors
por: Häggman, Michael, et al.
Publicado: (2022)

TRUS-MR Fusion Biopsy of the Prostate: Radiological and Histological Correlation
por: Lavaerts, Michel, et al.
Publicado: (2016)

Editorial Comment: Comparison of pain levels in fusion prostate biopsy and standard TRUS-Guided biopsy
por: Diniz, Andre Luiz Lima
Publicado: (2020)

Effectiveness and Safety of Molecular-Targeted Therapy after Nivolumab Plus Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study
por: Iinuma, Koji, et al.
Publicado: (2022)

Role of Perilesional Sampling of Patients Undergoing Fusion Prostate Biopsies
por: Lombardo, Riccardo, et al.
Publicado: (2023)

Low Body Mass Index as a Predictive Factor for Postoperative Infectious Complications after Ureterorenoscopic Lithotripsy
por: Seike, Kensaku, et al.
Publicado: (2021)

Miliary Tuberculosis Following Transrectal Ultrasonography (TRUS)-Guided Prostate Biopsy
por: Kim, Chul Jang, et al.
Publicado: (2011)

An Magnetic Resonance Imaging–directed Targeted-plus-perilesional Biopsy Approach for Prostate Cancer Diagnosis: “Less Is More”
por: Hagens, Marinus J., et al.
Publicado: (2022)

A case of multiple metastatic sarcomatoid renal cell carcinoma with complete response to nivolumab
por: Tomioka, Masayuki, et al.
Publicado: (2021)

Prognostic Factors for Resolution Delay of Lower Urinary Tract Symptoms in Patients with Prostate Cancer after Low-Dose-Rate Brachytherapy
por: Taniguchi, Tomoki, et al.
Publicado: (2023)

Chronological Changes of Lower Urinary Tract Symptoms in Elderly Patients with Prostate Cancer after Low-Dose-Rate Prostate Brachytherapy
por: Tsuchiya, Kunihiro, et al.
Publicado: (2023)

491 Comparative Effectiveness of Single vs Combination Antibiotic Prophylaxis for TRUS-biopsy
por: Marino, Kaylee, et al.
Publicado: (2014)

The role of MRI/TRUS fusion biopsy in the diagnosis of clinically significant prostate cancer
por: Benelli, Andrea, et al.
Publicado: (2020)

Prostate Biopsy: What is the future of this old Procedure? The Multiparametric Magnetic Resonance Imaging MRI/TRUS fusion prostate biopsy
Publicado: (2015)

Patients’ experience with MRI-guided in-bore biopsy versus TRUS-guided biopsy in prostate cancer: a pilot study
por: Pizzoli, Silvia Francesca Maria, et al.
Publicado: (2020)

TRUS-Guided Target Biopsy for a PI-RADS 3–5 Index Lesion to Reduce Gleason Score Underestimation: A Propensity Score Matching Analysis
por: Chung, Jae Hoon, et al.
Publicado: (2022)

A prospective study on inter-operator variability in semi-robotic software-based MRI/TRUS-fusion targeted prostate biopsies
por: Derigs, Fabian, et al.
Publicado: (2021)

The prostate cancer detection rates of CEUS-targeted versus MRI-targeted versus systematic TRUS-guided biopsies in biopsy-naïve men: a prospective, comparative clinical trial using the same patients
por: Postema, A. W., et al.
Publicado: (2017)

A Nomogram Based on a TRUS Five-Grade Scoring System for the Prediction of Prostate Cancer and High Grade Prostate Cancer at Initial TRUS-Guided Biopsy
por: Xie, Shao Wei, et al.
Publicado: (2018)

Complication Rates After TRUS Guided Transrectal Systematic and MRI-Targeted Prostate Biopsies in a High-Risk Region for Antibiotic Resistances
por: Wenzel, Mike, et al.
Publicado: (2020)

Targeted 11C–choline PET-CT/TRUS software fusion-guided prostate biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy
por: Lazzeri, Massimo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_veh8ts8of27idjao7vs50gbqla